FDA extends timeline for implementing electric shock prohibition

Overview

The FDA has missed its self-imposed deadline to decide on banning electrical stimulation devices used on individuals with intellectual disabilities and autism. A new deadline has been set for November.

Background

The use of electrical stimulation devices (ESDs) for self-injurious behavior has been controversial, with significant opposition from disability advocates and health professionals. The FDA previously attempted to ban these devices, citing their potential for harm, but faced legal challenges.

Data Highlights

No numerical data or trial data was provided in the source material.

Key Findings

• The FDA missed its May deadline for a decision on banning ESDs.
• A new deadline for the decision has been set for November.
• UN officials have labeled the use of ESDs as a form of 'torture.'
• The Judge Rotenberg Center in Massachusetts remains the primary institution using ESDs.
• Professional organizations advocate for positive behavioral supports instead of ESDs.

Clinical Implications

Healthcare providers should be aware of the ongoing discussions regarding the use of ESDs and alternative behavioral interventions.

Conclusion

The FDA's extension of the decision timeline reflects the complexities surrounding the regulation of ESDs.

Related Resources & Content

1. Stat News, 2026 -- As FDA misses deadline on electric shock ban, disability advocates speak out
2. FEDERAL REGISTER, 2024 -- Proposed rule on electrical stimulation devices
3. The ASCO Post — FDA Proposes to Extend Its Tobacco Authority to Additional Tobacco Products, Including E-Cigarettes
4. Retinal Physician — FDA Extends Review Period
5. ada news — ADA urges FDA to reconsider proposed pathway for flavored e-cigarette authorizations
6. FEDERAL REGISTER
7. BJPsych Open (2025)
8. Oral tetracyclines are effective for acne vulgaris